FilingIndex
DEF 14AThe Ballot

CRESCENT BIOPHARMA, INC. files DEF 14A

Filed Apr 11, 2022 · 4y ago · Accession 0001558370-22-005265

Plain English

Proxy statement — executive pay, board nominees, and shareholder votes.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
CBIO
CIK
1253689
Form type
DEF 14A
Filing date
Apr 11, 2022
Report date
May 18, 2022
Document
tmb-20220518xdef14a.htm
Size
1.6 MB